Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T

Correction to: European Journal of Nuclear Medicine and Molecular Imaging

10.1007/s00259-022-05821-w

The publisher regrets that the Tables 2 and 3 that appear in the original article are incorrect. The correct tables appear below.

Table 2.

Self-absorbed dose rates to the nucleus per unit activity (Gy(Bq*s)^-1) depending on radionuclide localization (i.e. cell membrane and cytoplasm) and cellular dimension (i.e. minimum, average and maximum)

Floating set-up (spherical cells)
Dimension	Source compartment
	Cell membrane		Cytoplasm
	Lutetium-177	Actinium-225	Lutetium-177	Actinium-225
Minimum	2.02E-04	1.05E-01	3.67E-04	1.78E-01
Average	1.04E-04	5.63E-02	1.98E-04	1.01E-01
Maximum	6.40E-05	3.56E-02	1.23E-04	6.48E-02
Attached cells set-up (ellipsoidal shape)
Dimension	Source compartment
	Cell membrane		Cytoplasm
	Lutetium-177	Actinium-225	Lutetium-177	Actinium-225
Minimum	3.43E-04	1.61E-01	2.14E-04	1.09E-01
Average	1.65E-04	8.31E-02	1.16E-04	6.15E-02
Maximum	7.66E-05	4.05E-02	5.89E-05	3.23E-02
Contribution of the radioactive medium
	Lutetium-177		Actinium-225
	2.30E-11		4.57E-09

Table 3.

Absorbed dose (Gy) accumulated over 7 days (i.e. duration of clonogenic survival assay) of either [^177Lu]Lu-PSMA-I&T or [²²⁵Ac]Ac-PSMA-I&T treatment. The absorbed dose is reported for 3 cellular dimension assumptions (i.e. average, minimum and maximum) in order to provide the average and maximum range of variation of the absorbed dose calculations

[177Lu]Lu-PSMA-I&T
		Dimension
Concentration (MBq/mL)	Average	Minimum	Maximum
0	0	0	0
0.1	0.74	1.48	0.37
0.2	1.48	2.96	0.74
0.3	2.22	4.43	1.11
0.4	2.96	5.91	1.48
0.5	3.70	7.39	1.85
[225Ac]Ac-PSMA-I&T
		Dimension
Concentration (kBq/mL)	Average	Minimum	Maximum
0	0	0	0
0.037	0.08	0.16	0.04
0.1	0.22	0.42	0.11
0.185	0.41	0.78	0.21
0.25	0.56	1.05	0.29
0.37	0.83	1.55	0.42
0.5	1.12	2.10	0.57
0.75	1.67	3.15	0.86

The original article has been corrected.